Description
An inhibitor of RET kinase (IC50 = 0.4 nM); selective for RET kinase over VEGFR2/KDR (IC50 = 109 nM); reduces the number of abdominal contractions induced by colorectal distension in acetic acid-sensitized rats when administered at 10 mg/kg twice per day
Formal name: 4-(4-ethoxy-1,6-dihydro-6-oxo-3-pyridinyl)-2-fluoro-N-[5-(2,2,2-trifluoro-1,1-dimethylethyl)-3-isoxazolyl]-benzeneacetamide
Synonyms:
Molecular weight: 467.4
CAS: 1627856-64-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|Other Receptor Tyrosine Kinases||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cell Biology|Cell Signaling||Research Area|Immunology & Inflammation|Gastric Disease|IBS